FDA NEWS

UPDATE 2-FDA hit for slow progress on improving food safety - Reuters
WASHINGTON, June 12 (Reuters) - U.S. health officials have not made good on their promise last year to make food safer, lawmakers and others said on Thursday, as investigations widened to find the source of the latest outbreak of Salmonella that has
Source: www.reuters.com

FDA issues precautionary note on silver fillings - Forbes
Silver dental fillings contain mercury, and the government for the first time is warning that they may pose a safety concern for pregnant women and young children. The Food and Drug Administration posted the precaution on its Web site earlier this
Source: www.forbes.com

Source of tainted tomatoes may remain a mystery, FDA says - Los Angeles Times
Federal officials said Thursday that they might never learn which farms produced tainted tomatoes that have now sickened 228 people in 23 states with a rare form of salmonella. "At this stage of the investigation there is no guarantee that we will be
Source: www.latimes.com

Food Safety Plan by U.S. FDA Lacks Costs, Timeline (Update2) - Bloomberg
June 12 (Bloomberg) -- The U.S. Food and Drug Administration has failed to provide costs or deadlines for a plan to improve food safety even as tainted tomatoes have sickened Americans, according to a report to Congress. The agency oversees the
Source: www.bloomberg.com

FDA backs NYC in dispute over calories on menus - MSN MoneyCentral
NEW YORK (AP) - The Food and Drug Administration believes the city has a right to force chain restaurants to post calorie counts on menu boards, a government lawyer told a federal appeals court on Thursday, but the court did not immediately decide
Source: moneycentral.msn.com

GE Healthcare says FDA OKs AdreView application for priority review - CNBC
SAN FRANCISCO (Thomson Financial) - General Electric Co.'s GE Healthcare said Thursday the Food and Drug Administration has accepted its AdreView application for priority review. AdreView is a molecular imaging agent for the detection of
Source: www.cnbc.com

UPDATE 3-US senator seeks FDA probe of Glaxo's Paxil data - Reuters
WASHINGTON, June 12 (Reuters) - U.S. Sen. Charles Grassley asked regulators on Thursday to investigate whether drugmaker GlaxoSmithKline Plc (GSK.L: Quote , Profile , Research )(GSK.N: Quote , Profile , Research ) withheld data about a risk of
Source: www.reuters.com